Notably, HCC patients with higher RPL32 expression levels displayed worse prognosis in terms of overall survival, progression‐free survival, and disease‐specific survival in multiple databases (Figure 2A–F). This evidence concerns the gene RPL32 and hepatocellular carcinoma.